Throughout the course of this presidential election year, an array of industry and sector exchange traded funds have been affected. For example, earlier in the year, biotechnology ETFs were plagued by rhetoric on high drug prices from both political parties. Conversely, markets seem to have reconciled that regardless of which party wins the White House [...]
↧